Click on image to enlarge (or visit the web site).Here's the press release:Centocor, Inc. announced today the launch of MEDVERSATION(TM) (http://www.medversation.com), an extensive web-based resource designed to facilitate more-informed conversations between U.S. physicians and their patients about the efficacy and safety of REMICADE(R) (infliximab). This interactive web application, in development [...]
Lab Soft News |
November 23rd, 2008 |
Email this
In two previous posts, I began to explore both the similarities and differences between LISs and LIMs (see: LIS vs. LIMS: It's Time to Blend the Two Types of Lab Information Systems, LIMS and Preclinical Workflow: Another Dimension of the LIS/LIMS Discussion). Larry Wimberly of Wimberly Consulting Services, who has [...]
At an article today entitled "Medtronic Says Device for Spine Faces Probe" (Wall St. Journal, Nov. 19, 2008, subscription required) the WSJ reports another major medical device manufacturer, Medtronic, faces a probe for promoting unapproved uses of its technologies, which is improper:Doctors can deploy FDA-approved drugs and products any way [...]
PharmaGossip |
November 23rd, 2008 |
Email this
Astrazeneca shares fell over 4% Wednesday after the U.S. Federal Drug Administration approved a generic version of its asthma treatment Pulmicort Respules, sparking fears a generic version will now be launched.[...]
pharmalot |
November 23rd, 2008 |
Email this
Two days after lashing into Fred Goodwin, who hosts "The Infinite Mind" on National Public Radio, US Senator Chuck Grassley is now investigating Best Practice, a pharmaceutical consulting firm that Goodwin helped establish in the late '90's. Among the many services that have been offered by the firm - marketing [...]
ContractPharma |
November 23rd, 2008 |
Email this
Patheon (Booth 2209) has signed a master service agreement with Omnicare Clinical Research for distribution of clinical trial materials in Europe and Asia Pacific. Omnicare's clinical supplies division will provide Patheon's customers with various clinical supply services that include monitoring, distribution and return accountability. The agreement now enables Patheon to [...]
BizJournals |
November 23rd, 2008 |
Email this
Jeffrey Ubben has resigned his seat on Omnicare Inc.’s board of directors, citing his company’s decreased investment in the pharmacy services firm. (OCR)[...]
BizJournals |
November 23rd, 2008 |
Email this
Brooke Army Medical Center (BAMC) has been selected as a site for a new clinical trial that will evaluate the effectiveness of shockwave therapy for treating complex wounds in a military trauma hospital environment.[...]
FierceBiotech |
November 23rd, 2008 |
Email this
The FDA has approved GlaxoSmithKline and Ligand Pharmaceuticals' Promacta (eltrombopag). The drug treats a rare immune condition called thrombocytopenia purpura, in which a patient's immune system attacks its own platelets. Promacta is the first oral thrombopoietin receptor agonist therapy for the treatment of adult patients with chronic ITP. Release[...]
FierceBiotech |
November 23rd, 2008 |
Email this
Last year was one of the bleakest on record in terms of new drug approvals. Only 18 new molecular entities were approved by the FDA--the lowest number since 1983. The first half of 2008 was nothing to brag about either, as the industry seemed to be destined to repeat its [...]
medgadget |
November 23rd, 2008 |
Email this
The FDA has given Innocoll's (Dublin, Ireland) CollaRx® Gentamicin surgical implant fast track designation to speed through Phase III clinical trials. The device, thought to decrease risk of surgical site infection in patients with diabetes and obesity, has already received EU marketing approval. From the product page: CollaRx® Gentamicin Surgical [...]
Sangamo BioSciences, a developer of novel DNA-binding proteins for therapeutic gene regulation and modification, has announced top-line data from its SB-509-601 clinical trial, one of Sangamo's three Phase II clinical studies from its ZFP therapeutic program to develop SB-509 for diabetic neuropathy.[...]
Celgene Cellular Therapeutics, a wholly owned subsidiary of Celgene Corporation, has announced that the FDA has accepted the company's investigational new drug application to initiate a clinical trial using PDA001, an immunomodulatory therapy utilizing human placenta-derived stem cells obtained via the company's proprietary processes.[...]
pharmalot |
November 10th, 2008 |
Email this
The 25 percent staff reduction, which follows sluggish sales of its flagship Byetta diabetes med, is designed to save more than $100 million next year. After the dust clear, Amylin will have 1,800 employees. You may recall that, last summer, there were six deaths among patients with pancreatitis who took [...]
The FDA has even the neuroscience crowd scratching their heads. Some folks from the Neurotechnology Industry Organization, a trade group for neuroscience companies, and three of its members stopped by Health Blog HQ today. Our chat really heated up when it turned to the current regulatory environment. While recognizing that [...]
pharmalot |
November 10th, 2008 |
Email this
Two months ago, Hawthorn Pharmaceuticals launched Zamicet, an oral solution approved by the FDA to treat moderate to moderately severe pain for children two years and older. Zamicet, which contains hydrocodone bitartrate and acetaminophen, is also a controlled substance and is listed as a Schedule III drug, which means it [...]
CA-San Francisco, Our client is the industry's only company exclusively focused on driving clinical trial performance at the site level, offering assistance and advocacy to research centers - directly and through their[...]
Clinical trials 2 positions available - SAS programmer + clinical trial experience + SAS certified in Santa Clara, CA SAS programmer + Clinical trial experience... (From Dice)[...]
This position is responsible for overall clinical study management. A team player that has the ability to work well with many different functions to support the overall program[...]
JOB SUMMARY: The Clinical Trial Coordinator's role is to support clinical trial start up, maintenance and close out activities, as well as provide coordination of other[...]
